Abeona activates UF Health as 8th ZEVASKYN treatment center
Abeona Therapeutics activated University of Florida Health in Gainesville as the eighth Qualified Treatment Center for ZEVASKYN for RDEB patients.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Abeona Therapeutics activated University of Florida Health in Gainesville as the eighth Qualified Treatment Center for ZEVASKYN for RDEB patients.
Abeona Therapeutics said University of Florida Health in Gainesville, Florida was activated as its newest qualified treatment center for ZEVASKYN.